Oncolytic Newcastle Disease Virus and Photodynamic Therapy as Dual Approach for Breast Cancer Treatment

Asian Pac J Cancer Prev. 2024 Sep 1;25(9):3111-3118. doi: 10.31557/APJCP.2024.25.9.3111.

Abstract

Objective: We hypothesized that attacking cancer cells by combining various modes of action can hinder them from taking the chance to evolve resistance to treatment. Incorporation of photodynamic therapy (PDT) with oncolytic virotherapy might be a promising dual approach to cancer treatment.

Methods: NDV AMHA1 strain as virotherapy in integration with aminolaevulinic acid (ALA) using low power He-Ne laser as PDT in the existing work was examined against breast cancer cells derived from Iraqi cancer patients named (AMJ13). This combination was evaluated using Chou-Talalay analysis.

Results: The results showed an increased killing rate when using both 0.01 and 0.1 Multiplicity of infection (MOI) of the virus when combined with a dose of 6172.8 photons/gm (ph/gm) of PDT focused on cancer cells.

Conclusion: integration of the attenuated NDV-AMHA1 strain with photodynamic therapy has a synergistic killing effect on breast cancer cells in vitro, suggesting that this strategy could have clinical application to overcome breast cancer.

Keywords: Aminolaevulinic acid (ALA); Breast Cancer cells; He-Ne laser; Photodynamic therapy; virotherapy.

MeSH terms

  • Aminolevulinic Acid / pharmacology
  • Aminolevulinic Acid / therapeutic use
  • Breast Neoplasms* / drug therapy
  • Breast Neoplasms* / therapy
  • Combined Modality Therapy
  • Female
  • Humans
  • Newcastle disease virus*
  • Oncolytic Virotherapy* / methods
  • Oncolytic Viruses
  • Photochemotherapy* / methods
  • Photosensitizing Agents* / therapeutic use
  • Tumor Cells, Cultured

Substances

  • Photosensitizing Agents
  • Aminolevulinic Acid